Celldex Therapeutics Inc stock is traded at $27.96, with a volume of 751,760. It is up +1.49% in the last 24 hours and down -7.69% over the past month. Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Previous Close:
$27.55
Open:
$27.82
24h Volume:
751,760
Relative Volume:
0.92
Market Cap:
$2.20B
Revenue:
$866.00K
Net Income/Loss:
-$283.65M
P/E Ratio:
-
EPS:
-$4.27
Net Cash Flow:
-$226.25M
1W Performance:
-3.02%
1M Performance:
-7.69%
6M Performance:
-9.51%
1Y Performance:
+11.53%
1-Day Range:
$27.16$28.54
1-Week Range:
$27.16$29.31
52-Week Range:
$22.33$45.14
Celldex Therapeutics Inc Stock (CLDX) Company Profile
Name
Celldex Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
908-200-7500Address
53 FRONTAGE ROAD, HAMPTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS